Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.002.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.57M | 785.50K | 397.00K | 673.30K | 1.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 29.10K | 6.90K | 6.90K | 6.90K | 6.90K |
| Prepaid Expenses | 45.20K | 46.60K | 48.80K | 60.10K | 41.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.64M | 839.00K | 452.70K | 740.30K | 1.24M |
|
|
|||||
| Total Current Assets | 1.64M | 839.00K | 452.70K | 740.30K | 1.24M |
| Net Property, Plant & Equipment | 215.00K | 95.40K | 111.60K | 130.80K | 145.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.20K | 7.20K | 7.20K | 7.20K | 7.20K |
| Total Assets | 2.36M | 1.59M | 1.32M | 1.51M | 2.03M |
|
|
|||||
| Total Accounts Payable | 793.90K | 526.50K | 827.80K | 798.20K | 514.40K |
| Total Accrued Expenses | 7.77M | 7.86M | 7.35M | 7.15M | 7.15M |
| Short-term Debt | 1.57M | 1.62M | 1.62M | 1.62M | 1.62M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 56.10K | 24.30K | 35.50K | 46.90K | 57.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.18M | 10.03M | 9.83M | 9.61M | 9.34M |
|
|
|||||
| Total Current Liabilities | 10.18M | 10.03M | 9.83M | 9.61M | 9.34M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.57M | 1.62M | 1.62M | 1.62M | 1.62M |
| Capital Leases | 128.00K | 34.50K | 37.70K | 40.50K | 42.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.31M | 10.06M | 9.86M | 9.66M | 9.38M |
|
|
|||||
| Common Stock & APIC | 42.71M | 40.68M | 39.88M | 39.68M | 39.62M |
| Retained Earnings | -55.92M | -54.41M | -53.69M | -53.09M | -52.23M |
| Treasury Stock & Other | 22.00K | 22.00K | 22.00K | 22.00K | 22.00K |
| Total Common Equity | -13.19M | -13.71M | -13.79M | -13.39M | -12.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
|
|
|||||
| Total Common Equity | -13.19M | -13.71M | -13.79M | -13.39M | -12.59M |
| Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.96M | -8.47M | -8.55M | -8.15M | -7.36M |
|
|
|||||